Home › Funds › D. E. Shaw & Co › CABA
D. E. Shaw & Co position in CABA
CABALETTA BIO INC · Health Care
Latest position (Q2 2026)90.65K sh
Reported value held$281.93K
Portfolio Weight0.00%
First reportedQ1 2024
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 16.11K | $274.85K | New |
| Q3 2024 | 33.96K | $160.31K | New |
| Q4 2024 | 16.60K | $37.69K | Reduce |
| Q1 2026 | 189.41K | $509.52K | New |
| Q2 2026 | 90.65K | $281.93K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CABA
- BlackRock Inc 10.75M sh · $33.45M · Q2 2026
- Norges Bank Investment Management 4.11M sh · $12.79M · Q2 2026
- Geode Capital Management 3.46M sh · $10.76M · Q2 2026
- Vanguard Group 4.42M sh · $9.68M · Q4 2025
- Franklin Resources 2.41M sh · $7.51M · Q2 2026
- Goldman Sachs Group 2.21M sh · $6.88M · Q2 2026
- Millennium Management 2.07M sh · $6.43M · Q2 2026
- Marshall Wace 1.57M sh · $4.87M · Q2 2026
- Renaissance Technologies 1.54M sh · $4.77M · Q2 2026
- UBS Group AG 1.47M sh · $4.58M · Q2 2026
- Two Sigma Investments 1.41M sh · $4.39M · Q2 2026
- Morgan Stanley 1.35M sh · $4.18M · Q2 2026